Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001Vertical integration of major ...

Researchers discovered that the spatial orientation of ligands plays a more critical role than mere incorporation. They ...

This cover highlights the article ZBTB48 is a priming factor regulating B-cell-specific CIITA expression by Grishma Rane, Dennis Kappei and colleagues. The study identifies how ZBTB48, represented as ...

The collaboration will focus on gene vector and mRNA bioprocess solutions and services ... further optimization of the development platform and commercial production of GMP-compliant mRNA, plasmid and ...

About IMNN-001 Immunotherapy Designed using IMUNON's proprietary TheraPlas ® platform technology, IMNN-001 is an IL-12 DNA plasmid vector encased in a nanoparticle delivery system that enables cell ...

1 Molecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), Faculty of Chemistry, University of ...

Captain T Cell will manufacture a TCR-T cell therapy aimed at treating solid tumour patients in Phase I trials.

The vectordbbench command can optionally read some or all the options from a yaml formatted configuration file. VectorDBBench is not just an offering of benchmark results for mainstream vector ...